Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Imatinib Mesylate Reduces Bone Marrow Fibrosis and Overwhelms the Adverse Prognostic Impact of Reticulin Formation in Patients with Chronic Myeloid Leukemia

Eda Tanrikulu Simsek, MD, Ahmet Emre Eskazan, MD, Mahir Cengiz, MD, M. Cem Ar, MD PhD, Seda Ekizoglu, PhD, Ayse Salihoglu, MD, Emine Gulturk, MD, Tugrul Elverdi, MD, Seniz Ongoren Aydin, MD, Ahu Senem Demiroz, MD, Ayse Nur Buyru, MD, Zafer Baslar, MD, Ugur Ozbek, MD PhD, A. Burhan Ferhanoglu, MD, Yildiz Aydin, MD, Nukhet Tuzuner, MD Professor, Teoman Soysal, MD

Blood (2015) 126 (23): 2783.

https://doi.org/10.1182/blood.V126.23.2783.2783

Published: 2015

Journal Articles

Real-Life Data and a Single Center Experience on Dasatinib-Induced Pulmonary Arterial Hypertension in Patients with Philadelphia Chromosome-Positive Leukemias

Nurgul Ozgur Yurttas, MD, Sevil Sadri, MD, Dilek Keskin, MD, Selin Berk, MD, Isil Erdogan Oztunali, MD, Fevzi Firat Yalniz, MD, Ayse Salihoglu, MD, Ahmet Emre Eskazan, MD, M. Cem Ar, MD PhD, Seniz Ongoren Aydin, MD, Zafer Baslar, MD, Yildiz Aydin, MD, Teoman Soysal, MD

Blood (2015) 126 (23): 4037.

https://doi.org/10.1182/blood.V126.23.4037.4037

Published: 2015

Journal Articles

The Prognostic Value of Serum APRIL Levels in Patients with Chronic Lymphocytic Leukemia

Sinem Nihal Esatoglu, MD, Dilek Keskin, MD, Muge Kutnu, MD, Tugrul Elverdi, Fellow, Ayse Salihoglu, Hematologist, Ahmet Emre Eskazan, Hematologist, Muhlis Cem AR, Associate Professor, Seniz Ongoren Aydin, Associate Professor, Zafer Baslar, Professor Doctor, Yildiz Aydin, Professor Doctor, Hanife Uzun, Professor Doctor, Teoman Soysal, Professor Doctor

Blood (2014) 124 (21): 5648.

https://doi.org/10.1182/blood.V124.21.5648.5648

Published: 2014

Journal Articles

Next-Generation Sequencing Of The BCR-ABL1 Kinase Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance

Yucel Erbilgin, Ahmet Emre Eskazan, Ozden Hatirnaz Ng, PhD, Ayse Salihoglu, Tugrul Elverdi, MD, Sinem Firtina, Suzin Catal Tatonyan, Seniz Ongoren Aydin, Muhlis Cem Ar, Zafer Baslar, Muge Sayitoglu, PhD, A. Burhan Ferhanoglu, Yildiz Aydin, Ugur Ozbek, Teoman Soysal

Blood (2013) 122 (21): 384.

https://doi.org/10.1182/blood.V122.21.384.384

Published: 2013

Journal Articles

Multidrug Resistance Gene (MDR1) C3435T Polymorphism and Imatinib Response in Patients with Chronic Myeloid Leukemia

Ahmet Emre Eskazan, Suzin Catal Tatonyan, Ayse Salihoglu, Emine Gulturk, M. Cem Ar, Seniz Ongoren Aydin, Zafer Baslar, A. Burhan Ferhanoglu, Nukhet Tuzuner, Yildiz Aydin, Ugur Ozbek, Teoman Soysal

Blood (2011) 118 (21): 1692.

https://doi.org/10.1182/blood.V118.21.1692.1692

Published: 2011

Journal Articles

Ten-Year Follow-up Data of Diffuse Large B-Cell Lymphoma Patients: Single Center Experience

Murat Ozbalak, M. Cem Ar, Ayse Salihoglu, Emine Gulturk, Ahmet Emre Eskazan, Hematologist, Seniz Ongoren Aydin, Zafer Baslar, Professor Doctor, Teoman Soysal, Professor Doctor, Yildiz Aydin, Professor Doctor, Nukhet Tuzuner, Professor Doctor, A. Burhan Ferhanoglu, Professor Doctor

Blood (2011) 118 (21): 5223.

https://doi.org/10.1182/blood.V118.21.5223.5223

Published: 2011

Journal Articles

Imatinib for Chronic Myeloid Leukemia Patients: A Single Institution Experience

Suzan Alp, Ayse Salihoglu, Ahmet Emre Eskazan, Emine Gulturk, M. Cem Ar, Seniz Ongoren Aydin, Zafer Baslar, Ayse Nur Buyru, Ugur Ozbek, A. Burhan Ferhanoglu, Yildiz Aydin, Teoman Soysal

Blood (2011) 118 (21): 4429.

https://doi.org/10.1182/blood.V118.21.4429.4429

Published: 2011

Journal Articles

CLLU1 Gene Expression Level As a Prognostic Parameter in Patients with Chronic Lymphocytic Leukemia

Mustafa Sevinc, Ahmet Emre Eskazan, Aydin Karabulut, Msc, Suzin Catal Tatonyan, Emine Gulturk, Ayse Salihoglu, Seniz Ongoren Aydin, M. Cem Ar, Zafer Baslar, A. Burhan Ferhanoglu, Nukhet Tuzuner, Yildiz Aydin, Ugur Ozbek, Teoman Soysal

Blood (2011) 118 (21): 4603.

https://doi.org/10.1182/blood.V118.21.4603.4603

Published: 2011

NARROW

Imatinib Mesylate Reduces Bone Marrow Fibrosis and Overwhelms the Adverse Prognostic Impact of Reticulin Formation in Patients with Chronic Myeloid Leukemia

Real-Life Data and a Single Center Experience on Dasatinib-Induced Pulmonary Arterial Hypertension in Patients with Philadelphia Chromosome-Positive Leukemias

The Prognostic Value of Serum APRIL Levels in Patients with Chronic Lymphocytic Leukemia

Next-Generation Sequencing Of The BCR-ABL1 Kinase Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance

Multidrug Resistance Gene (MDR1) C3435T Polymorphism and Imatinib Response in Patients with Chronic Myeloid Leukemia

Ten-Year Follow-up Data of Diffuse Large B-Cell Lymphoma Patients: Single Center Experience

Imatinib for Chronic Myeloid Leukemia Patients: A Single Institution Experience

CLLU1 Gene Expression Level As a Prognostic Parameter in Patients with Chronic Lymphocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only